FDA+ channel feed – Endpoints News

FDA+ channel feed

Safety concerns lead FDA to reject Akebia's kidney drug

4 years ago

Fed watchdog confirms Trump-era Covid ad campaign shenanigans — and millions misspent

4 years ago

Biden likely to sign a bill that would crack down on China's chokehold on the antibiotic supply

4 years ago

FDA calls for Hatch-Waxman tweak, accelerated approval reforms in President Biden's 2023 budget proposal

4 years ago

Amylyx shares routed on skeptical adcomm docs — but did the FDA leave an open door on unmet ALS need?

4 years ago

UCB lands FDA approval in newest indication for newly-acquired Zogenix epilepsy drug

4 years ago

Paul Hudson's rare disease pivot takes a small step forward, as Niemann-Pick drug wins Japan approval

4 years ago

EMA OKs two new drugs — J&J's BCMA CAR-T for multiple myeloma, AstraZeneca's Evusheld — plus 5 label expansions

4 years ago

Intarcia may finally get its post-CRL review, although FDA points to Covid and another hearing as taking priority

4 years ago

No more accelerated approvals for PI3K? Biotech cites FDA's 'current position' as it warns of major delay

4 years ago

With competitors circling, ViiV wins another label update for long-acting HIV injectable Cabenuva

4 years ago

FDA serves up a quick rejection of China-only data with a CRL for Lilly's PD-1

4 years ago

Novartis' radiopharma drug wins approval in tough-to-treat prostate cancer patients

4 years ago

Ahead of FDA committee to discuss new ALS drug, the jury remains out on how much benefit is enough for approval

4 years ago

FDA forced to reset how it regulates some ophthalmic drugs following court loss

4 years ago

With latest Keytruda OK, Merck edges into GlaxoSmithKline’s (small) PD-1 turf

4 years ago

Cadila's sterile injectable site in India hit with a Form 483 following a rare international inspection for FDA

4 years ago

Marinus completes its turnaround with first approval of sole drug, winning a PRV for its efforts

4 years ago

Accelerated approval reforms take center stage at House hearing, but a way forward remains unclear

4 years ago

China working on concessions to help homegrown companies stay on US exchanges — report

4 years ago

Pfizer pitches 4th Covid-19 vaccine shot for elderly despite mixed data from Israel

4 years ago

White House sounds the alarm on Covid-19 vaccine, monoclonal supply shortages

4 years ago

Genome editing products: FDA recommends at least 15 years of follow-up after clinical trials

4 years ago

FDA orders Incyte to hold up yet again in the hunt for blockbuster franchise

4 years ago

First page Previous page 87 88 899091 92 93 Next page Last page